Your browser doesn't support javascript.
loading
Pregnancy-Related Complications in Patients With Fibromuscular Dysplasia: A Report From the European/International Fibromuscular Dysplasia Registry.
Pappaccogli, Marco; Prejbisz, Aleksander; Ciurica, Simina; Bruno, Rosa Maria; Aniszczuk-Hybiak, Anna; Bracalente, Irene; De Backer, Tine; Debiève, Frédéric; Delmotte, Philippe; Di Monaco, Silvia; Jarraya, Faiçal; Gordin, Daniel; Kosinski, Przemyslaw; Kroon, Abraham A; Maas, Angela H E M; Marcon, Denise; Minuz, Pietro; Montagud-Marrahi, Enrique; Pasquet, Agnès; Poch, Esteban; Rabbia, Franco; Stergiou, George S; Tikkanen, Ilkka; Toubiana, Laurent; Vinck, Wouter; Warchol-Celinska, Ewa; Van der Niepen, Patricia; de Leeuw, Peter; Januszewicz, Andrzej; Persu, Alexandre.
Afiliación
  • Pappaccogli M; From the Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Italy (M.P., S.D.M., F.R.).
  • Prejbisz A; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
  • Ciurica S; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
  • Bruno RM; Department of Hypertension, National Institute of Cardiology, Warsaw, Poland (A. Prejbisz, A.A.-H., E.W.-C., A.J.).
  • Aniszczuk-Hybiak A; Cardiology Department, Marie Curie Civil Hospital, CHU Charleroi, Lodelinsart, Belgium (S.C.).
  • Bracalente I; Department of Clinical and Experimental Medicine University of Pisa, Italy (R.M.B., I.B.).
  • De Backer T; INSERM U970 Team 7, Paris Cardiovascular Research Centre - PARCC & Université de Paris, Paris, France (R.M.B.).
  • Debiève F; Department of Hypertension, National Institute of Cardiology, Warsaw, Poland (A. Prejbisz, A.A.-H., E.W.-C., A.J.).
  • Delmotte P; Department of Clinical and Experimental Medicine University of Pisa, Italy (R.M.B., I.B.).
  • Di Monaco S; Department of Cardiovascular Diseases, University Hospital Ghent, Belgium (T.D.B.).
  • Jarraya F; Obstetrics Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium (F.D.).
  • Gordin D; Service de Cardiologie, CHU Ambroise Paré, Mons, Belgium (P.D.).
  • Kosinski P; From the Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Italy (M.P., S.D.M., F.R.).
  • Kroon AA; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
  • Maas AHEM; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
  • Marcon D; Service de Néphrologie, CHU Hédi Chaker, Sfax, Tunisie/Unité de Recherche 12ES14 Pathologie rénale, Faculté de medicine, Sfax (F.J.).
  • Minuz P; Helsinki Hypertension Centre of Excellence (D.G., I.T.), University of Helsinki, Helsinki University Hospital, Finland.
  • Montagud-Marrahi E; Abdominal Center Nephrology (D.G., I.T.), University of Helsinki, Helsinki University Hospital, Finland.
  • Pasquet A; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Finland (D.G.).
  • Poch E; Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland (P.K.).
  • Rabbia F; Department of Internal Medicine, Division of General Internal Medicine, Section Vascular Medicine (A.A.K., P.d.L.), Maastricht University Medical Centre, Maastricht University, the Netherlands.
  • Stergiou GS; CARIM School for Cardiovascular Diseases (A.A.K., P.d.L.), Maastricht University Medical Centre, Maastricht University, the Netherlands.
  • Tikkanen I; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands (A.H.E.M.M.).
  • Toubiana L; Department of Medicine, Unit of General Medicine and Hypertension, University of Verona, Italy (D.M., P.M.).
  • Vinck W; Department of Medicine, Unit of General Medicine and Hypertension, University of Verona, Italy (D.M., P.M.).
  • Warchol-Celinska E; Service de Cardiologie, CHU Ambroise Paré, Mons, Belgium (P.D.).
  • Van der Niepen P; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
  • de Leeuw P; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (M.P., S.D.M., A. Pasquet, A. Persu).
  • Januszewicz A; Service de Cardiologie, CHU Ambroise Paré, Mons, Belgium (P.D.).
  • Persu A; From the Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Italy (M.P., S.D.M., F.R.).
Hypertension ; 76(2): 545-553, 2020 08.
Article en En | MEDLINE | ID: mdl-32639884
ABSTRACT
Current literature suggests a higher risk of pregnancy-related complications in patients with renal fibromuscular dysplasia (FMD). The aim of our study was to assess the nature and prevalence of pregnancy-related complications in patients subsequently diagnosed with FMD. A call for participation was sent to centers contributing to the European/International FMD Registry. Patients with at least 1 pregnancy were included. Data on pregnancy were collected through medical files and FMD characteristics through the European/International FMD Registry. Data from 534 pregnancies were obtained in 237 patients. Despite the fact that, in 96% of cases, FMD was not diagnosed before pregnancy, 40% of women (n=93) experienced pregnancy-related complications, mostly gestational hypertension (25%) and preterm birth (20%), while preeclampsia was reported in only 7.5%. Only 1 patient experienced arterial dissection and another patient an aneurysm rupture. When compared with patients without pregnancy-related complications, patients with complicated pregnancies were younger at FMD diagnosis (43 versus 51 years old; P<0.001) and had a lower prevalence of cerebrovascular FMD (30% versus 52%; P=0.003) but underwent more often renal revascularization (63% versus 40%, P<0.001). In conclusion, the prevalence of pregnancy-related complications such as gestational hypertension and preterm birth was high in patients with FMD, probably related to the severity of renal FMD. However, the prevalence of preeclampsia and arterial complications was low/moderate. These findings emphasize the need to screen hypertensive women for FMD to ensure revascularization before pregnancy if indicated and appropriate follow-up during pregnancy, without discouraging patients with FMD from considering pregnancy.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Complicaciones del Embarazo / Nacimiento Prematuro / Displasia Fibromuscular Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Hypertension Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Complicaciones del Embarazo / Nacimiento Prematuro / Displasia Fibromuscular Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Hypertension Año: 2020 Tipo del documento: Article